Yayın: Real life efficacy and tolerability of tenofovir alafenamde fumarate in liver transplant recipients: A multicenter study
| dc.contributor.author | Yapali, S. | |
| dc.contributor.author | Gökcan, H. | |
| dc.contributor.author | Harputluoğlu, M. | |
| dc.contributor.author | Ellik, Z. M. | |
| dc.contributor.author | Gökçen, P. | |
| dc.contributor.author | Adanır, H. | |
| dc.contributor.author | Coşar, A. M. | |
| dc.contributor.author | Durak, S. | |
| dc.contributor.author | Arı, D. | |
| dc.contributor.author | Mehdiyev, S. | |
| dc.contributor.author | Koc, E. S. | |
| dc.contributor.author | Güzelbulut, F. | |
| dc.contributor.author | Alkim, H. | |
| dc.contributor.author | Ekmen, N. | |
| dc.contributor.author | Yıldırım, A. E. | |
| dc.contributor.author | Ünsal, Y. | |
| dc.contributor.author | Teker, T. | |
| dc.contributor.author | Etik, D. O. | |
| dc.contributor.author | Vatansever, S. | |
| dc.contributor.author | Balaban, Y. | |
| dc.contributor.author | Özdil, K. | |
| dc.contributor.author | Arslan, M. | |
| dc.contributor.author | Kayhan, M. A. | |
| dc.contributor.author | Gündüz, F. | |
| dc.contributor.author | Kıyıcı, M. | |
| dc.contributor.author | Boyacıoğlu, S. | |
| dc.contributor.author | Şimşek, H. | |
| dc.contributor.author | Tozun, N. | |
| dc.contributor.author | Dinçer, D. | |
| dc.contributor.author | İdilman, R. | |
| dc.contributor.author | TASL Viral Hepatiti | |
| dc.contributor.buuauthor | TEKER, TUFAN | |
| dc.contributor.buuauthor | KIYICI, MURAT | |
| dc.contributor.department | Uludağ Üniversitesi | |
| dc.contributor.researcherid | EAB-6931-2022 | |
| dc.contributor.researcherid | FHW-0015-2022 | |
| dc.date.accessioned | 2024-12-03T05:38:31Z | |
| dc.date.available | 2024-12-03T05:38:31Z | |
| dc.date.issued | 2022-08-01 | |
| dc.description | Bu çalışma, 04-07, Mayıs 2022 tarihlerinde İstanbul[Türkiye]’de düzenlenen Joint Annual International Congress of ILTS, ELITA and LICAGE Kongresi‘nde bildiri olarak sunulmuştur. | |
| dc.description.sponsorship | Int Liver Transplantat Soc | |
| dc.description.sponsorship | ELITA | |
| dc.description.sponsorship | LICAGE | |
| dc.identifier.eissn | 1534-6080 | |
| dc.identifier.endpage | 108 | |
| dc.identifier.issn | 0041-1337 | |
| dc.identifier.issue | 8S | |
| dc.identifier.startpage | 107 | |
| dc.identifier.uri | https://hdl.handle.net/11452/48793 | |
| dc.identifier.volume | 106 | |
| dc.identifier.wos | 000840849700177 | |
| dc.indexed.wos | WOS.SCI | |
| dc.indexed.wos | WOS.ISTP | |
| dc.language.iso | en | |
| dc.publisher | Lippincott Williams & Wilkins | |
| dc.relation.journal | Transplantation | |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Science & technology | |
| dc.subject | Life sciences & biomedicine | |
| dc.subject | Immunology | |
| dc.subject | Surgery | |
| dc.subject | Transplantation | |
| dc.title | Real life efficacy and tolerability of tenofovir alafenamde fumarate in liver transplant recipients: A multicenter study | |
| dc.type | Other | |
| dc.type.subtype | Meeting Abstract | |
| dspace.entity.type | Publication | |
| local.contributor.department | Uludağ Üniversitesi | |
| local.indexed.at | WOS | |
| relation.isAuthorOfPublication | 56aceb2a-0b8c-46a8-9e0c-06df3908b667 | |
| relation.isAuthorOfPublication | b364b52b-c416-4987-b080-93f6f81ecb3e | |
| relation.isAuthorOfPublication.latestForDiscovery | 56aceb2a-0b8c-46a8-9e0c-06df3908b667 |
